F12 is the first lysin-based treatment with the potential to be used multiple times on a single patient, making it ideal to treat particularly persistent drug-resistant and drug-sensitive infections.

The team then synthesized a lysin from a bacteriophage, or virus that attacks bacteria, that infects S. hominis. During in vitro experiments, this lysin was found to target only S. hominis ...

A research team has synthesized a lysin that during in vitro experiments targets bacteria responsible for producing odors in human armpits. Body odor from the armpits comes from bacteria ...

About Bioharmony Therapeutics, Inc. Bioharmony Therapeutics, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class lysin-based antimicrobial ...

An Osaka Metropolitan University-led research team has synthesized a lysin that during in vitro experiments targets bacteria responsible for producing odors in human armpits.